The effect of blood pressure on cognitive performance. An 8-year follow-up of the Tromsø Study, comprising people aged 45–74 Years by Hestad, Knut et al.
fpsyg-11-00607 April 19, 2020 Time: 12:18 # 1
ORIGINAL RESEARCH




Politécnico do Porto, Portugal
Reviewed by:
Claudio Lucchiari,
University of Milan, Italy
Michel Burnier,






This article was submitted to
Psychology for Clinical Settings,
a section of the journal
Frontiers in Psychology
Received: 04 September 2019
Accepted: 13 March 2020
Published: 21 April 2020
Citation:
Hestad K, Engedal K, Schirmer H
and Strand BH (2020) The Effect
of Blood Pressure on Cognitive
Performance. An 8-Year Follow-Up
of the Tromsø Study, Comprising
People Aged 45–74 Years.
Front. Psychol. 11:607.
doi: 10.3389/fpsyg.2020.00607
The Effect of Blood Pressure on
Cognitive Performance. An 8-Year
Follow-Up of the Tromsø Study,
Comprising People Aged 45–74 Years
Knut Hestad1,2* , Knut Engedal3, Henrik Schirmer4,5,6 and Bjørn Heine Strand3,7
1 Department of Health Studies, Inland Norway University of Applied Sciences, Elverum, Norway, 2 Department of Research,
Innlandet Hospital Trust, Ottestad, Norway, 3 Norwegian National Advisory Unit on Ageing and Health, Vestfold County
Hospital Trust, Tønsberg, Norway, 4 Department of Cardiology, Akerhus University Hospital, Lørenskog, Norway, 5 Institute
of Clinical Medicine, University of Oslo, Oslo, Norway, 6 Institute of Clinical Medicine, UiT-The Arctic University of Norway,
Tromsø, Norway, 7 Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway
Background: The relationship between blood pressure (BP) and cognition is complex
were age appears to be an intervening variable. High and low BP have been associated
with cognitive deficits as part of the aging process, but more studies are needed,
especially in more recent birth cohorts.
Methods: The study sample comprised 4,465 participants, with BP measured at
baseline in the Tromsø Study, Wave 6 in 2007–2008 (T0), and cognition assessed at
follow-up 8 years later, in 2015–2016 in Tromsø Study 7 (T1). Age at T0 was 45–
74 years, and at T1 it was 53–82 years. Cognition was assessed with three tests: The
Mini Mental State Examination (MMSE), the Digit Symbol Test, and the Twelve-word Test.
The associations between BP and cognition were examined specifically for age and sex
using linear regression analysis adjusted for baseline BP medication use, education and
body mass index (kg/m2).
Results: BP was associated with cognition at the 8-year follow-up, but the association
differed according to age and sex. In men, higher systolic blood pressure (SBP)
and diastolic blood pressure (DBP) at a young age (45–55 years of age) was
associated with poorer cognition; the association was reversed at older ages, especially
for those above 65 years of age. In women, the associations were generally
weaker than for men, and sometimes in the opposite direction: For women, a
higher SBP was associated with better cognition at a younger age and higher
SBP poorer cognition at older ages – perhaps due to an age delay in women
compared to men. Digit Symbol Test results correlated best with BP in a three-
way interaction: BP by age by sex was significant for both SBP (p = 0.005) and
DBP (p = 0.005).
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Conclusion: Increased SBP and DBP at the younger age was clearly associated with
poorer cognitive function in men 8 years later; in women the associations were weaker
and sometimes in the opposite direction. Our findings clearly indicate that interactions
between age and sex related to BP can predict cognitive performance over time. Men
and women have different age trajectories regarding the influence of BP on cognition.
Keywords: blood pressure, cognitive performance, aging, sex differences, dementia
INTRODUCTION
The association between blood pressure (BP) and cognitive
function is a complex one. It has been suggested that both
high and low BP may be predictors of cognitive deficits in later
years (Qiu et al., 2005), and it seems that the timing of the BP
measurement is a key variable. As the population ages, an increase
in mean BP has been observed – particularly a rise in systolic BP
(SBP) (Franklin, 2006; McEniery et al., 2016). A recent study has
shown that for those born in 1960 and later, however, BP does not
increase with age (Hopstock et al., 2015).
High BP in midlife is a risk factor for stroke and for dementia
arising from Alzheimer’s Disease (AD) and cerebrovascular
disorders (Launer et al., 1995; Kilander et al., 1998; Swan
et al., 1998a,b; Kivipelto et al., 2001; Yamada et al., 2003;
Whitmer et al., 2005; Kimm et al., 2011; Joas et al., 2012).
Skoog et al. (1996) suggest that high BP in midlife harms
the brain, which thereafter results in BP decline and cognitive
impairment. This conclusion fits with several findings of low
BP later in late life being related to cognitive impairment and
dementia (Hestad et al., 2005; Gabin et al., 2017). Furthermore,
it has been shown that both high and declining DBP are
associated with global brain atrophy, as indicated by magnetic
resonance imaging (Heijer et al., 2003). However, the brain
has an autoregulation system that may compensate for change
in blood pressure, but if big changes occur abruptly, this
autoregulation system may not be able to compensate. Joas
et al. (2012) analyzed women only, in a longitudinal study, and
concluded that high systolic pressure may be an indicator of
large artery stiffness with an increased risk of dementia, whereas
diastolic pressure could be a marker of peripheral resistance,
which may be related to white matter lesions. Hypertension
may start a degenerative process and in the long run result
in brain damage and a decline in blood pressure, which is
seen in people before development of dementia symptoms
(Joas et al., 2012). Thus, both high pressure related to arterial
stiffness and the later low pressure may result in reduced
oxygen supply to the brain, which is needed for efficient
cognitive performance.
However, two meta-analyses revealed no association between
hypertension and AD (Guan et al., 2011; Power et al., 2011),
although a large Hawaiian cohort study showed a correlation
between high BP in midlife and cognitive dysfunction due to
dementia of mild degree (Launer et al., 1995; Launer et al.,
2000). Another US study concluded that midlife, but not late-life
elevated SBP, was associated with cognitive decline (Gottesman
et al., 2014). In line with this finding, in the Whitehall II cohort
study, midlife SBP as low as 130 mmHg and higher was associated
with increased risk of dementia, whereas no such association was
seen for late-life SBP (Abell et al., 2018). Hebert et al. (2004), who
studied participants 65 and older, found no association between
elevated BP and cognitive decline, a finding that may reflect
the age of their participants, who may have been too old to
demonstrate an association.
Few studies have examined the relationship between high
BP and cognition; most studies have examined dementia as
the outcome of high BP. Thus, we sought to examine whether
baseline BP over an 8-year period was associated with impaired
cognition and if this association differed between age groups and
sexes in a population based study.
Men and women seem to have different developmental stories
regarding blood pressure regulations during life (Joyner et al.,
2016). Women also have different patterns regarding incident of
myocardial infarction with lower rates for women at least until
95 years of age compared to men (Barrett-Connor, 2013).
We also wanted to examine whether the use of
antihypertensive drugs attenuated any observed association.
METHODS
Study Population
The Tromsø Study is a longitudinal population-based
multipurpose study initiated in 1974 with surveys and
examinations to examine lifestyle-related diseases. Earlier
participants were invited to join the study and new participants
were recruited in 1979, 1986, 1994, 2001, 2007, and 2015
(Jacobsen et al., 2012; Eggen et al., 2013). In our study, data
from the last two study waves are used: Tromsø Study Wave 6
(our baseline) and Wave 7 (our follow-up). The Tromsø study
has a complex sampling design, with an attendance rate of 66%
in Tromsø 6 and 65% in Tromsø 71. Hereafter, to reflect our
study design, Tromsø 6 is denoted T0 and Tromsø 7 is denoted
T1, with BP measured at baseline in T0 and its association with
cognition at follow-up in T1.
Our study sample comprised 4,465 Tromsø study participants
(Table 1), born between 1933 and 1962, with baseline SBP and
DBP measurements at T0 when participants were 45–74 years
old; their cognition was assessed at follow-up at T1, when
they were 53–82 years old. Thus, to be included in our study,
participants must have had BP measurements at T0 and a valid
cognitive test score at T1.
Every person in Tromsø aged 60–74 was invited to join our
sample, together with a 40% random sample of those inhabitants
1www.tromsoundersokelsen.no


















TABLE 1 | Flow-chart, study sample were we also included one of the cognitive tests.














0. Invited to baseline examination, 45–74 years, T0 12,054
1a. Did not participate in T0 3,241
1b. Participated in T0 8,813 59.9 (7.8) 52 36 35 137.7 (21.9) 27.1 (4.3) 40.3 (12.6)
2a. No valid BP measurement in T0 34
2b. Valid BP measurements in T0 8,779 59.9 (7.8) 52 36 35 137.7 (21.9) 27.1 (4.2) 40.3 (12.6)
3a. Not invited, died or emigrated before T1 416 65.1 (6.4) 40 30 56 143.3 (24.1) 26.9 (4.3) 33.0 (11.9)
3b. Invited to T1, Phase I 8,363 59.7 (7.8) 52 36 34 137.4 (21.7) 27.1 (4.2) 40.7 (12.5)
4a. Did not participate in T1, Phase I 1,895 61.0 (8.0) 52 31 42 139.9 (22.7) 27.3 (4.5) 37.3 (12.3)
4b. Participated in T1, Phase I 6,468 59.3 (7.7) 53 37 31 136.7 (21.4) 27.0 (4.2) 41.5 (12.4)
5a. Not invited to T1, Phase II (cognition) 1,172 53.5 (8.5) 42 45 28 132.1 (20.7) 27.0 (4.3) 38.3 (9.8)
5b. Invited to T1, Phase II (cognition) 5,296 60.6 (6.9) 55 36 32 137.7 (21.4) 27.0 (4.1) 41.5 (12.4)
6a. Did not participate in T1 Phase II 783 61.8 (7.3) 53 32 37 140.0 (22.8) 26.9 (4.2) 39.0 (13.0)
6b. Participated in T1 Phase II 4,513 60.4 (6.8) 55 37 31 137.3 (21.1) 27.0 (4.1) 41.9 (12.3)
7a. Died before T1 data collection was finished 17
7b. Alive when T1 data collection was finished 4,496 60.3 (6.8) 55 37 31 137.2 (21.1) 27.0 (4.1) 41.9 (12.3)
8a. T0 BP measurements out of range∗ 31
8b. T0 BP measurements within range 4,465
9. Final Study Sample 4,465 60.3 (6.8) 55 37 31 136.8 (20.3) 27.0 (4.1) 42.0 (12.3)
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younger than 60 years. Thus, invitations were sent to 12,054
Tromsø inhabitants aged 45–74, 8,813 of whom participated
(Table 1). At T1, those 8,363 still alive and residing in Tromsø
were contacted again for participation in T1, and 6,468 agreed to
participate. Of this group of 6,468, a subset of 5,296 was invited
to participate in a clinical examination including cognitive
assessment, and 4,465 participated. Thus, our study sample
comprised 51% of the baseline participants (4,465/8,813).
Our sample size was reduced because of a combination of
missing random participants and those who dropped out due
to poor health. In addition, 5% of the initial sample is missing
because of death (433 died before attending T1) Among the 8,363
invited to T0, 1,895 or 22% of the initial sample did not agree
to participate. This group differed from the participating group
in that they were older, had less education, had higher baseline
BP, higher baseline BMI, poorer baseline self-reported health,
and had lower baseline cognitive scores (Table 1). Another
large group of T1 participants (n = 1,172) were omitted from
cognitive assessment at T1 because of the sampling design; fewer
members of this group were women, and group members were
substantially younger than those who were invited for cognitive
assessment, and they had lower prevalence of poor self-reported
health (Table 1).
Our final study sample (Table 1, item number 9) was
slightly older (60.3 years vs. 59.9 years) than the entire baseline
population (Table 1, item number 1b), consisted of more women
(55% vs. 52%), were slightly more educated (37% vs. 36%), had
lower BP at T0 (SBP = 136.8 mmHg vs. 137.7 mmHg), had
lower prevalence of poor self-rated health (31% vs. 35%), and
had better cognition at T0 (42.0 vs. 40.3 on the Digit Symbol
Test of Wechsler Adult Intelligence Scale (WAIS). BMI at T0 was
comparable in the two populations (27.0 kg/m2 vs. 27.1 kg/m2).
Blood Pressure Measurements
Trained health personnel measured each participant’s BP on the
upper right arm with a sized cuff based on arm circumference
at the health survey. At both T0 and T1, BP was measured
three times with an oscillometric digital automatic device:
Dinamap ProCare 300 monitor, GE Healthcare, Norway. The
measurements were separated by a 1-min interval after a 2-
min seated rest, and the mean of the two final readings used in
the analysis. (BP was modeled as a continuous variable in the
analyses). BP level at T0, but not at T1, was regressed against
cognition at T1, as we wanted to investigate how baseline BP
affected later cognition. Nevertheless, BP at T1 was included for
descriptive purposes, in order to facilitate a longitudinal pattern
and change in BP from T0 to T1 for each birth cohort.
Cognitive Tests
The following cognitive tests were applied: The Mini Mental
State Examination (MMSE) (Folstein et al., 1975), the WAIS,
Digit Symbol Test (Wechsler, 1955, 1967), and the Twelve-word
Test (Rogne et al., 2013a) (a modification of the California
Verbal Learning Test). The MMSE is a well-known screening test
for dementia. The test includes orientation, attention, memory,
language and visual-spatial skills. It includes 11 questions and
takes 7–10 min to administer.
The MMSE is divided into two sections, the first based on
vocal responses from the examinee, and covers orientation,
memory, and attention; the maximum score is 21. The second
part covers the ability to name, follow verbal and written
commands, write a sentence spontaneously, and copy a polygon
figure. The maximum score on the second part is nine. The total
maximum score is 30.
In the Digit Symbol, a subtest from the Wechsler Adult
Intelligence Scale (WAIS), the examinee is shown a series of
symbols that are paired with numbers from 1 to 9. Using a key,
the examinee is asked to consecutively fill in as many as possible
of the blank spaces with the corresponding symbol as quickly
and accurately as possibly whereby he or she draws each symbol
under its corresponding number, within a 90 s. The score is the
correct filled in symbols within the time limit. Participants were
instructed not to skip symbols. Of all the Wechsler tests, the Digit
Symbol Test is considered the most sensitive test of brain damage,
even when the damage is minimal (Hirschenfang, 1960; Lezak,
1995); it is regarded as a test of processing speed and attention.
The 12 word memory test examine short-time verbal memory
with immediate free recall of 12 nouns shown written on a board
and also pronounced one at a time with a 5 s interval. The
participants then had 2 min to recall the words, and one point
was given for each word correctly recalled, and should therefore
be able to discover memory difficulties (Palmer et al., 2003). The
above were the reasons for choosing the tests in the Tromsø study
(Rogne et al., 2013b; Jorde et al., 2015).
All together there were 10 study nurses, trained by either
a specialist in geriatric diseases or a neuropsychologist at T0
and T1 respectively, who administered the tests. The tests were
administered on the second visit (of two) as a part of the
health examination in the Tromsø study, in especially dedicated
study facilities.
Covariates at Baseline
Self-reported use of antihypertensive drugs (ever used vs.
never used) was included in the regression analyses as a
covariate. Of the total participants, 80 (1.8%) had terminated
their medication, and they were grouped as ever users.
Education was grouped as low (corresponding to 9 years),
medium (10–12 years), or high (13+ years). BMI (kg/m2)
was included as a categorical variable (<20, 20–24, 25–29,
30+), and age was included as a continuous variable. Self-
reported history of stroke was reported at both T0 and T1
(yes/no) and those reporting yes (n = 207) were omitted in
a sensitivity analysis. Poor self-rated health was included as a
dichotomous variable (1 = Very bad/bad/neither good nor bad,
0 = Good/Excellent).
Statistical Methods
Stata/SE 15.0 was used for all analyses (StataCorp LLC).
First, age trends in BP at T0 and T1 were investigated
in linear regression, and gender differences in trends were
investigated including age by gender interactions. Secondly,
the association between baseline BP and cognitive function
at follow-up was investigated with linear regression, adjusted
by age, sex, BP medication use, education, poor self-rated
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TABLE 2 | Background table.
Birth cohort Age T0 (2007/2008) Age T1 (2015/2016) N T0 T1 Change from T0 to T1
Men Systolic blood pressure
1953–1962 45–54 53–62 420 131.4 (16.2) 131.9 (16.9) 0.5 (16.4)
1943–1952 55–64 63–72 1,001 138.2 (18.6) 136.3 (18.2) −1.8 (18.3)
1933–1942 65–74 73–82 577 143.7 (19.3) 140.7 (18.8) −3.0 (20.1)
Women
1953–1962 45–54 53–62 585 123.9 (18.2) 125.9 (17.7) 2.1 (15.9)
1943–1952 55–64 63–72 1,217 135.5 (19.9) 136.5 (19.9) 1.0 (19.8)
1933–1942 65–74 73–82 665 145.7 (21.2) 146.2 (21.3) 0.5 (23.3)
Men Diastolic blood pressure
1953–1962 45–54 53–62 420 82.2 (9.7) 79.4 (8.9) −2.8 (9.1)
1943–1952 55–64 63–72 1,001 82.6 (10.1) 77.6 (9.7) −5.0 (9.8)
1933–1942 65–74 73–82 577 80.7 (9.4) 75.7 (9.4) −5.0 (10.1)
Women
1953–1962 45–54 53–62 585 75.0 (9.8) 73.9 (9.4) −1.1 (8.6)
1943–1952 55–64 63–72 1,217 75.9 (9.6) 73.6 (9.4) −2.3 (9.1)
1933–1942 65–74 73–82 665 75.2 (9.7) 73.4 (9.7) −1.8 (10.3)
BP at baseline in Tromsø Wave 6 (T0) and at follow-up in Tromsø Wave 7 (T1) and change. N = 4,465.
FIGURE 1 | Digit Symbol Test at T1 and the association with BP measurements at T0. Age is measured at T0, 8 years before the cognitive assessment at T1. SBP,
Systolic blood pressure; DBP, Diastolic blood pressure. Estimated in linear regression, adjusted by baseline covariates [BP medication, education, self-reported
health, and body mass index (BMI)]. All the 2-way and 3-way interaction terms – blood pressure by age by sex – are included. Test of slope different from zero:
*p < 0.1, **p < 0.05.
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FIGURE 2 | MMSE scores at T1 and the association with blood pressure measurements at T0. Age is measured at T0, 8 years before the cognitive assessment at
T1. SBP, Systolic blood pressure; DBP, Diastolic blood pressure. Estimated in linear regression, adjusted by baseline covariates [BP medication, education,
self-reported health, and body mass index (BMI)]. All the 2-way and 3-way interaction terms – blood pressure by age by sex – are included. Test of slope different
from zero: *p < 0.1, **p < 0.05.
health, and BMI. All two- and three-way interaction terms
among BP, age, and sex were included. To visualize the results
of the complex regression model, the post-hoc margins and
marginsplot commands in Stata were applied. By the use of these
commands, we provided estimates of the BP–cognition slopes
at specified ages for men and women and could test whether
slopes were significantly different from zero (no association).
Statistical significance was defined as p ≤ 5%. In some settings
we also showed p ≤ 10%, to indicate values near the significance
level of 5%. The project was approved by the Regional
Committees for Medical and Health Research Ethics (2016/389
REK sør-øst B).
RESULTS
Blood Pressure by Age, Birth Cohort, and
Sex
SBP increased with age (cross-sectional) at both T0 and T1
(Table 2). Women had lower SBP than men in the youngest age
groups (<65 years), whereas women had higher SBP than men
in the oldest age group (65–74 years). Thus, cross-sectionally,
women’s SBP across age had a steeper increase than men’s
SBP both at T0 and T1. When we examined birth cohorts
longitudinally, we noted a trend toward lower SBP from T0
to T1 in men, despite their 8-year age increase. This tendency
was present for all birth cohorts, but was most pronounced
for the oldest groups (>54 years at T0). In women, however,
the SBP increased over time, especially in the younger group,
45–54 years at T0.
Cognition by Age, Sex, and Education
Overall, cognitive performance declined with age, at a similar
pace for men and women, on all three cognitive measures.
Scores on the Digit Symbol Test declined by 0.7 units per
year (p < 0.001), and scores on both MMSE and the Twelve-
word Test declined by 0.07 units per year (p < 0.001). Men
had significantly (p < 0.001) poorer performance than women
did on all three cognitive tests, adjusted by age and education.
Men’s scores averaged 4.2 points lower than women’s scores
on the Digit Symbol Test, 0.4 lower on the MMSE, and 0.6
units lower on the Twelve-word Test. Education was significantly
associated with better cognitive performance on all three tests, in
a step-wise pattern (adjusted by age and sex). Participants with
higher education scored 8.4 points higher on the Digit Symbol
Test than did participants with less education, 1.4 higher on
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FIGURE 3 | The Twelve-word Test scores at T1 and the association with blood pressure measurements at T0. Age is measured at T0, 8 years before the cognitive
assessment at T1. SBP, Systolic blood pressure; DBP, Diastolic blood pressure. Estimated in linear regression, adjusted by baseline covariates [BP medication,
education, self-reported health, and body mass index (BMI)]. All the 2-way and 3-way interaction terms – blood pressure by age by sex – are included. Test of slope
different from zero: *p < 0.1, **p < 0.05.
the MMSE, and 1.3 higher on the Twelve-word Test (all tests
p < 0.001).
The Relationship Between Baseline BP
and Cognition at Follow-Up
The association between baseline BP and cognition at follow-up
was related to both age and sex. Furthermore, results were not
consistent across the three cognitive outcome measures, with the
Digit Symbol Test most strongly associated with BP. There was a
three-way interaction term for this measure: BP by age by sex was
significant for SBP (p = 0.005) and DBP (p = 0.005).
Results for Men
In younger men (45–55 years), higher SBP and DBP levels
were significantly associated with poorer performance on the
Digit Symbol Test at the 8-year follow-up, whereas higher BP
among older participants (65–74 years) was associated with better
cognition at follow-up, especially for DBP (age by SBP interaction
term: p = 0.039; age by DBP interaction term: p < 0.001)
(Figure 1). For the other two cognitive measures (MMSE and
Twelve-word Test), the associations with SBP were weaker, and
the age by SBP interaction terms were not significant for either
measure (Figures 2, 3). For DBP, however, similar age patterns
were observed for the other cognitive measures as for the Digit
Symbol Test, with a significant age by DBP interaction term
for the Twelve-word Test (p = 0.043) and a non-significant
association for MMSE (p = 0.100).
Results for Women
Contrary to the findings for men, women’s higher SBP in the
older age groups (65–74 years) was associated with significantly
poorer performance on the Digit Symbol Test, although there
was no significant association at younger ages (The age by SBP
interaction term was not significant p = 0.051; see Figure 1.)
For the other two cognitive measures, there were no significant
age by SBP interactions. There were no significant DBP by age
interactions, and the association between SBP and cognition
was generally weak and non-significant in women, except for
performance on the Twelve-word Test, in which higher DBP and
higher SBP at younger ages (45–55 years) were associated with
significantly better cognition (Figures 2, 3).
Sensitivity Analyses
When we omitted the 207 (4.6%) participants with self-
reported history of stroke at either T0 or T1, almost identical
Frontiers in Psychology | www.frontiersin.org 7 April 2020 | Volume 11 | Article 607
fpsyg-11-00607 April 19, 2020 Time: 12:18 # 8
Hestad et al. Blood Pressure and Cognition
results were obtained, and did not change any of the main
findings or conclusions.
DISCUSSION
In this large population-based health examination study, we
found that for the youngest cohort of men (45–55 years of age),
higher BP was associated with poorer cognitive performance 8
years later. This tendency was not seen for the women. For
the oldest men (above 65), however, higher BP was associated
with better cognition. For the oldest women, on the other hand,
higher SBP was associated with poorer cognitive performance
8 years later, whereas in the younger cohort there were no
clear trends between BP and cognition. Thus, we suggest
a tendency for differences in association of elevated BP on
cognitive performance between the two sexes. To our knowledge,
this is the first time such a sex by BP interaction has been
reported for cognition.
In our study, in accordance with a recent report from
the Tromsø study (Hopstock et al., 2015), SBP was stable in
women (actually a small increase in mean score) and falling
with age in men.
The study by Hopstock et al. suggests that BP does not increase
with age. However, some limitations were discussed, the major
one being that 40% of subjects had only one BP measurement
and there was not a complete follow-up of subjects. Thus, there
might be some selection bias impacting the age trend in BP.
Another study from Norway (Holmen et al., 2016) came to the
same conclusion in a large population based study, namely that
blood pressure levels decreased substantially from mid 1980s to
mid 2000s. Even though the blood pressure medication increased
this only explained a small part of the blood pressure reduction as
the decrease was also considerable in those who reported to never
use such a medication. The decrease was biggest in those who
were in the oldest age group (80+). Our study, partially supports
such a suggestion regarding blood pressure decrease with age
especially regarding diastolic BP. Examination of the data cross
sectional however, there are still large age differences.
There is clearly a difference between women and men in the
way BP seems to relate to cognition in the aging process. Could
it be related to their different trajectories regarding heart disease?
Even though men and women experience the same risk factors
for myocardial infarction, they demonstrate a different pattern
in incidents of myocardial infarction (Barrett-Connor, 2013).
An epidemiological study from the same cohort as our study
have shown an accelerated myocardial infarction risk in young
men compared to young women, which decreases as they
age (Albrektsen et al., 2016). The incident rates increased
with age in both sexes, with lower rates for women until
95 years of age. This gap between the sexes declined with
age as a result of a more pronounced flattening of risk level
changes in middle-aged men (Conroy et al., 2003; Barrett-
Connor, 2013; Albrektsen et al., 2016; Selmer et al., 2017).
Despite the decrease in incidence in older men, women
never catch up (Albrektsen et al., 2016; Barrett-Connor, 2013).
Women usually get cardiovascular disease 6–10 years later
than men do, despite similar risk factors. Albrektsen et al.
(2016) conclude that this observation in myocardial infarction
cannot be explained by differences in established coronary
heart disease risk factors. The different pattern between men
and women may be explained by different development of
blood pressure by biological aging, e.g., that women have
longer life expectancy and thereby different development of
blood pressure. As there is no acceleration in risk after
menopause, hormonal factors cannot be solely responsible for
the observed sex differences. But as women tend to increase
more in BMI by age than men do, the estrogen produced by
fatty tissue may still play a part in protecting women from
cognitive dysfunction (Jacobsen et al., 2001). Even so, we cannot
exclude the possibility that hormones, especially estrogen, can
affect the brain and create the difference between the sexes
regarding cognitive aging. For elderly women, postmenopausal
hypertension, with changes in their estrogen/androgen ratio;
activation of the Renin-angiotensin system, sympathetic nervous
system, and the endothelin-1 system may result in more
inflammation and increased vasoconstrictor eicosanoids (Song
et al., 2019). These changes may influence sex differences in
the aging process and in cognitive performance. There seems
to be a link between cardiovascular health and cognition even
before the development of dementia. We cannot rule out the
possibility that some of the inferior cognition we see in our
research is the beginning of Alzheimer’s disease as men also
get Alzheimer at a younger age than women. The adverse
effect of high BP on cognition among the youngest male
cohort was most pronounced for the Digit Symbol Test (less
so but to some degree, also for the Twelve-word Test and
MMSE), which is no surprise, given that the Digit Symbol
Test is highly sensitive to cognitive impairment. Our data
indicate, as for studies related to myocardial infarctions, that
the effect of elevated BP on cognition occurs later in life
for women compared to men (significant BP × age × sex
interaction). As for the MMSE it must be noted that all the
mean scores are above 23, and that this test is sensitive to the
development of dementia; the MMSE may be less sensitive to
minor cognitive deficits, however. A score below 23 is seen as
indicating possible dementia, and a score above this cutoff is
considered normal or close to normal, depending on educational
level and age (Folstein et al., 1975). Our results may suggest
that increasing BP impairs cognition in men, but we cannot
exclude the possibility of reverse causality: cognitive impairment
(from possible cerebral affection) may create a drop in BP
(Joas et al., 2012). The association between BP and cognition
is more uncertain in the oldest group in our sample, because
the associations point in different directions, and with less
clear associations between BP and cognition. In a previous
population-based study of people above the age of 80 years,
we showed that low BP was highly associated with low scores
on the MMSE (Hestad et al., 2005; Hestad and Engedal, 2006).
In the present study, however, the older women were more
like the younger men, as high SBP was associated with poor
cognitive performance.
We did not observe any influence of the use of anti-
hypertensive drugs. Perhaps the analyses were unable to unearth
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the benefits of the drugs with regard to performance on
cognitive tests. Alternatively, the brain damage related to
high BP before the treatment with medication may not have
been ameliorated, especially given that more than 60% of the
participants on treatment were above treatment target. There are
conflicting results from other studies related to antihypertensive
therapy and the effects on cognitive functioning. Although the
McGuinness et al. (2009) meta-analysis found no association
between the lowering of BP and cognitive impairment, Tzourio
et al. (2003) found that reducing BP had a positive effect on
cognition – but only by reducing the rate of stroke. A recent
randomized clinical trial demonstrated that intensive SBP control
can reduce the development of mild cognitive impairment
(Williamson et al., 2019).
Our sensitivity analyses indicated that those with the lowest
and highest BP at baseline dropped out of the study at follow-up,
which may indicate that those with the worst prognosis regarding
cognition were not included in the analyses. Dropout from
longitudinal population-based studies usually reflects sickness
or poorer functioning among dropouts than among those
who remain in the study. The dropout rate could therefore
reflect that both those with a low and high pressure have
developed a worsening of their situation, and perhaps cognitive
decline and dementia.
The participants in this study were all volunteers, and
supposedly no one had dementia – at least no one was
diagnosed with dementia.
One strength of our study was the large number of
participants. Few researchers have had the opportunity to
examine change in BP related to cognition in more than
4,000 participants.
A possible limitation in our study is selection bias due
to selective drop out from T0 to T1. Those participating in
both T1 and T0 differed from those who only participated in
T0 in that they had better self-reported health and cognition
at T0. They were also younger, had higher education, lower
baseline BP, and lower BMI. These biases were addressed by
adjustment of factors associated with the dropouts. However,
there may still be some bias that may have influenced
findings and thus our conclusions. This bias would likely
“mute” any true associations between BP and cognition. Four
hundred and sixteen participants (4.7%) were not invited to
T1 because they had emigrated or died before follow-up.
Of these 60% were men and 40% women. The observed
longitudinal decrease in BP in men, may to some degree be
due to a higher mortality compared to women with only
survivors with a lower BP remaining. Morbidity might be a
confounding factor, as well as a factor related to drop out
between T0 and T1. Unfortunately, we did not have morbidity
information, except from stroke history, and had to rely on
self-reported health status.
Another limitation regarding the difference between men and
women and the delay observed in these latter, may be due
to the fact that many of the younger women are still in the
premenopausal phase, even at the end of 8 years of follow-up. In
this phase of life, women may be at a lower risk of dementia and
cardio vascular events.
A third limitation of study was the fact that only three
cognitive tests were used. The Digit Symbol Test, which is
related to processing speed and attention, is considered to be
a highly sensitive test for brain damage, and the results of
this test performance were consistently affected primarily by
high BP, but also by low BP. The Twelve-word Test showed
some association with BP. We did not have any delayed
recall performance, but in populations such as these, the
correlation between immediate and delayed recall is usually high
(Nespollo et al., 2017).
Some of the earlier studies related to BP and dementia have
examined only women or only men. Both sexes were represented
in our study, no diagnosis of dementia was present before testing,
and we found a different trend in BP across age and sex.
In conclusion, high BP at baseline for the men, but not the
women, was clearly associated with reduced cognitive function
8 years later. Because it may be that in some brain disorders,
like small-vessel disease or Alzheimer’s disease, brain damage can
cause both cognitive deficits and a decrease in BP, we cannot
claim to have found a causal relationship, however.
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